G1 Therapeutics Inc
(GTHX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 194,387 | 103,812 | 118,380 | 132,675 | N/A |
| TOTAL | $195,183 | $104,661 | $119,035 | $133,768 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 558 | 510 | 516 | 333 | N/A |
| TOTAL | $558 | $510 | $516 | $333 | $N/A |
| Total Assets | $195,741 | $105,171 | $119,551 | $134,101 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,872 | 4,184 | 4,234 | 5,132 | 0 |
| Accrued Expenses | 8,635 | 7,520 | 6,187 | 5,278 | N/A |
| TOTAL | $12,507 | $11,704 | $10,421 | $10,410 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 79 | 79 | 0 | 0 | 0 |
| TOTAL | $79 | $79 | $N/A | $N/A | $N/A |
| Total Liabilities | $12,586 | $11,783 | $10,421 | $10,410 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,704 | 28,445 | 28,345 | 28,285 | N/A |
| Common Shares | 3 | 3 | 3 | 3 | N/A |
| Retained earnings | -149,528 | -129,118 | -112,137 | -96,536 | N/A |
| Other shareholders' equity | -8 | -8 | -8 | -8 | 0 |
| TOTAL | $183,155 | $93,388 | $109,130 | $123,691 | $N/A |
| Total Liabilities And Equity | $195,741 | $105,171 | $119,551 | $134,101 | $0 |